Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
armpit painful; aching; unable to move full range of motion; warm to touch; bruising; This non-serious case was reported by a consumer and described the occurrence of axillary pain in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included gastroesophageal reflux disease. Concomitant products included pantoprazole sodium sesquihydrate (Protonix). On 26-MAR-2025 20:00, the patient received Shingrix. On 28-MAR-2025, 2 days after receiving Shingrix, the patient experienced axillary pain (Verbatim: armpit painful), pain (Verbatim: aching), mobility decreased (Verbatim: unable to move full range of motion), skin warm (Verbatim: warm to touch) and contusion (Verbatim: bruising). The outcome of the axillary pain, pain, mobility decreased and skin warm were not resolved and the outcome of the contusion was not reported. It was unknown if the reporter considered the axillary pain, pain, mobility decreased, skin warm and contusion to be related to Shingrix. It was unknown if the company considered the axillary pain, pain, mobility decreased, skin warm and contusion to be related to Shingrix. Additional Information: GSK Receipt Date: 31-MAR-2025 The patient self-reported this case for herself. Consumer reported that she took the Shingrix vaccine on Wednesday at 8pm (from the date of reporting) and experienced armpit painful, aching, unable to move full range of motion, warm to touch, it moved into the above pictures Friday, Saturday and Sunday. The bruising started on Friday evening; she had reached out to her PCP (primary care physician) for Monday morning.
Gastroesophageal reflux disease
Protonix